Adoptive Immunotherapy Against Allogeneic Kidney Grafts in Dogs with Stable Hematopoietic Trichimerism

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 11, 2008, Pages 1201-1208

  Graves, Scott S ^a,b   Hogan, William J ^a   Kuhr, Christian ^a,b   Diaconescu, Razvan ^a   Harkey, Michael ^a   Sale, George E ^a,b   Stone, Brad ^c   Georges, George E ^a,b   Storb, Rainer ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Canine; Graft versus host disease; Kidney transplantation; Marrow transplantation; Multiple donors; Nonmyeloablative

Indexed keywords

HLA ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; DISEASE MARKER; DOG; DONOR SELECTION; ENTEROPATHY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; LIVER DISEASE; LYMPHOCYTIC INFILTRATION; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PERIPHERAL LYMPHOCYTE; SKIN DISEASE; TARGET ORGAN; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; DOGS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOTHERAPY, ADOPTIVE; KIDNEY TRANSPLANTATION; LYMPHOCYTE TRANSFUSION; MALE; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 53749094562     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.08.005     Document Type: Article

References (25)

1. Frederik J.H., van de Corput L., Marijt E.W.A., et al. Minor histocompatibility antigens in human stem cell transplantation. Exp Hematol 31 (2003) 743-751
2. Bleakley M., and Riddell S.R. Molecules and mechanisms of the graft-versus-leukaemia effect. Nate Rev Cancer 4 (2004) 371-380
3. Carnevale-Schianca F., Cignetti A., Capaldi A., et al. Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD. Blood 107 (2006) 3795-3803
4. Bishop M.R. Allogeneic hematopoietic stem cell transplantation for metastatic breast cancer (review). Haematologica 89 (2004) 599-605
5. Ringden O., and Le Blanc K. Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives (review). APMIS 113 (2005) 813-830
6. Childs R., Chernoff A., Contentin N., et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 343 (2000) 750-758
7. Tykodi S.S., Warren E.H., Thompson J.A., et al. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens. Clin Cancer Res 10 (2004) 7799-7811
8. Junghanss C., Takatu A., Little M.-T., et al. Adoptive immunotherapy against kidney targets in dog leukocyte antigen-identical mixed hematopoietic canine chimeras. Transplantation 75 (2003) 268-274
9. Taranova A.G., Georges G.E., Yunusov M., et al. Breaking tolerance in stable mixed chimeric dogs with low-dose TBI and donor or recipient lymphocyte infusion. [abstract]. Blood 102 Part 1 (2003) 76a
10. Lesnikova M., Nikitine A., Mason N., et al. Ex vivo expanded T regulatory (Treg) cells block conversion of mixed chimeras to complete donor chimerism. [abstract]. Blood 108 Part 2 (2006) 382b
11. Georges G.E., Storb R., Thompson J.D., et al. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation. Blood 95 (2000) 3262-3269
12. Graves S.S., Hogan W., Kuhr C.S., et al. Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning. Blood 110 (2007) 418-423
13. Fuchs E.J., and Matzinger P. Is cancer dangerous to the immune system? (review). Semin Immunol 8 (1996) 271-280
14. Wagner J.L., Burnett R.C., DeRose S.A., et al. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation 62 (1996) 876-877
15. Wagner J.L., Works J.D., and Storb R. DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing. Tissue Antigens 52 (1998) 397-401
16. Ladiges W.C., Storb R., and Thomas E.D. Canine models of bone marrow transplantation. Lab Anim Sci 40 (1990) 11-15
17. Storb R., Yu C., Wagner J.L., et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89 (1997) 3048-3054
18. Belldegrun A., Muul L.M., and Rosenberg S.A. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. Cancer Res 48 (1988) 206-214
19. Kuhr C.S., Allen M.D., Junghanss C., et al. Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras. Transplantation 73 (2002) 1487-1493
20. Li G.P., Zhang H., Zhu C.M., et al. Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma. World J Gastroenterol 11 (2005) 6288-6294
21. Sandmaier B.M., Storb R., Santos E.B., et al. Allogeneic transplants of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors. Blood 87 (1996) 3508-3513
22. Lupu M., Gooley T., Zellmer E., et al. Principles of peripheral blood mononuclear cell apheresis in a preclinical canine model of hematopoietic cell transplantation. J Vet Intern Med 22 (2008) 74-82
23. Matzinger P. The danger model: a renewed sense of self. Science 296 (2002) 301-305
24. Thomas J.M., Contreras J.L., Jiang X.L., et al. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 68 (1999) 1660-1673
25. Park W., Griffin M., Grande J.P., et al. Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplant. Transplantation 83 (2007) 1466-1476